SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
郑开心
Lv1
40 积分
2022-06-01 加入
最近求助
最近应助
互助留言
Microenvironment-responsive anti-PD-L1 × CD3 bispecific T-cell engager for solid tumor immunotherapy
13天前
已完结
Bispecific dendritic-T cell engager potentiates anti-tumor immunity
18天前
已完结
The company landscape for artificial intelligence in large-molecule drug discovery
4个月前
已完结
Therapy with oncolytic viruses: progress and challenges
9个月前
已完结
Rejuvenation of tumour-specific T cells through bispecific antibodies targeting PD-L1 on dendritic cells
11个月前
已完结
Activation-induced cell death in CAR-T cell therapy
1年前
已完结
Preclinical characterization and comparison between CD3/CD19 bispecific and novel CD3/CD19/CD20 trispecific antibodies against B-cell acute lymphoblastic leukemia: targeted immunotherapy for acute lymphoblastic leukemia
1年前
已完结
Addition of interleukin-2 overcomes resistance to neoadjuvant CTLA4 and PD1 blockade in ex vivo patient tumors
1年前
已完结
NK cells with tissue-resident traits shape response to immunotherapy by inducing adaptive antitumor immunity
1年前
已完结
Back on the scene: Advances and challenges in CD3-related drugs in tumor therapy
1年前
已完结
没有进行任何应助
没有进行任何互助留言
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论